Latest & greatest articles for otitis media

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on otitis media or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on otitis media and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for otitis media

24. Randomised controlled trial: Clinical failure is more common in young children with acute otitis media who receive a short course of antibiotics compared with standard duration Full Text available with Trip Pro

Randomised controlled trial: Clinical failure is more common in young children with acute otitis media who receive a short course of antibiotics compared with standard duration Clinical failure is more common in young children with acute otitis media who receive a short course of antibiotics compared with standard duration | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser (...) otitis media who receive a short course of antibiotics compared with standard duration Article Text Therapeutics/Prevention Randomised controlled trial Clinical failure is more common in young children with acute otitis media who receive a short course of antibiotics compared with standard duration Roderick P Venekamp 1 , Anne G M Schilder 2 Statistics from Altmetric.com Commentary on: Hoberman A , Paradise JL , Rockette HE , et al . Shortened antimicrobial treatment for acute otitis media in young

2017 Evidence-Based Medicine

25. Otitis media - chronic suppurative

Otitis media - chronic suppurative Otitis media - chronic suppurative - NICE CKS Share Otitis media - chronic suppurative: Summary Chronic suppurative otitis media (CSOM) is defined as 'a chronic inflammation of the middle ear and mastoid cavity, which presents with recurrent ear discharges (otorrhoea) through a tympanic perforation’. CSOM is assumed to be a complication of acute otitis media (AOM). The World Health Organization definition states that AOM is considered to be CSOM after at least (...) ? From age 1 month onwards. This CKS topic covers the assessment and management of suspected chronic suppurative otitis media (CSOM) in primary care. This CKS topic does not cover advice on treatments used for CSOM in secondary care, such as antibiotics, aural cleansing, or surgery. There are separate CKS topics on , , , and . The target audience for this CKS topic is healthcare professionals working within the NHS in the UK, and providing first contact or primary health care. How up-to-date

2017 NICE Clinical Knowledge Summaries

26. Shortened Antimicrobial Treatment for Acute Otitis Media in Young Children. Full Text available with Trip Pro

Shortened Antimicrobial Treatment for Acute Otitis Media in Young Children. Limiting the duration of antimicrobial treatment constitutes a potential strategy to reduce the risk of antimicrobial resistance among children with acute otitis media.We assigned 520 children, 6 to 23 months of age, with acute otitis media to receive amoxicillin-clavulanate either for a standard duration of 10 days or for a reduced duration of 5 days followed by placebo for 5 days. We measured rates of clinical (...) to 23 months of age with acute otitis media, reduced-duration antimicrobial treatment resulted in less favorable outcomes than standard-duration treatment; in addition, neither the rate of adverse events nor the rate of emergence of antimicrobial resistance was lower with the shorter regimen. (Funded by the National Institute of Allergy and Infectious Diseases and the National Center for Research Resources; ClinicalTrials.gov number, NCT01511107 .).

2016 NEJM Controlled trial quality: predicted high

27. Impact of Pediatric Acute Otitis Media on Child and Parental Quality of Life and Associated Productivity Loss in Malaysia: A Prospective Observational Study Full Text available with Trip Pro

Impact of Pediatric Acute Otitis Media on Child and Parental Quality of Life and Associated Productivity Loss in Malaysia: A Prospective Observational Study Acute otitis media (AOM) affects both child and parental quality of life (QoL). Data on QoL associated with AOM in Malaysia is sparse, and the burden of indirect costs have not been previously reported.To determine the effect of pediatric AOM on child and parental QoL in Malaysia and its economic impact (indirect costs).We utilized a set

2016 Drugs - real world outcomes

28. Otovent nasal balloon for otitis media with effusion

Otovent nasal balloon for otitis media with effusion Oto Otov vent nasal balloon for otitis media with ent nasal balloon for otitis media with effusion effusion Medtech innovation briefing Published: 15 March 2016 nice.org.uk/guidance/mib59 pathways Summary Summary Otovent is a balloon device designed to relieve the symptoms of otitis media with effusion, commonly known as glue ear. An Otovent kit consists of a nose piece and 5 latex balloons that are inflated by blowing through the nose. Four (...) dysfunction associated with glue ear (otitis media with effusion), or after flying, diving or pressure chamber treatment. It would most likely be used in children with glue ear during or after an active observation period following diagnosis, to help avoid the need for surgery. Effectiv Effectiveness and safety eness and safety No relevant evidence was found for the use of Otovent in adults. Four randomised controlled trials involving a total of 565 children showed statistically significant improvements

2016 National Institute for Health and Clinical Excellence - Advice

29. Purulent acute otitis media in children over 3 months

Purulent acute otitis media in children over 3 months Haute Autorité de Santé - Purulent acute otitis media in children over 3 months Fermer Choose language Accessibility Change contrast : Standards Reinforced icone Chercher icone plus Chercher My account My account Please fill in your email address to retrieve your email alerts subscriptions. Please fill in your email address to retrieve your newsletter subscriptions. You do not have a saved search Sélection No element in selection Services (...) Services Déclarer un événement indésirable grave Comment déclarer les EIGS Etre accrédité par la HAS Médecins exerçant une spécialité «à risques» Déposer une demande d'évaluation d'actes Modalités et procédures Organiser les soins, les parcours Coordination des soins, coopération entre professionnels Rechercher une recommandation, un guide, un médicament Rechercher une recommandation, un médicament, un guide Date : 09 November 2016 Purulent acute otitis media in children over 3 months Practice

2016 HAS Guidelines

30. Purulent acute otitis media in adults

Purulent acute otitis media in adults Haute Autorité de Santé - Purulent acute otitis media in adults Fermer Choose language Accessibility Change contrast : Standards Reinforced icone Chercher icone plus Chercher My account My account Please fill in your email address to retrieve your email alerts subscriptions. Please fill in your email address to retrieve your newsletter subscriptions. You do not have a saved search Sélection No element in selection Services Services Déclarer un événement (...) indésirable grave Comment déclarer les EIGS Etre accrédité par la HAS Médecins exerçant une spécialité «à risques» Déposer une demande d'évaluation d'actes Modalités et procédures Organiser les soins, les parcours Coordination des soins, coopération entre professionnels Rechercher une recommandation, un guide, un médicament Rechercher une recommandation, un médicament, un guide Date : 09 November 2016 Purulent acute otitis media in adults Practice guidelines - Posted on Nov 18 2016 The aim of this memo

2016 HAS Guidelines

31. Systematic review: Antibiotics administered for acute otitis media have modest benefits and adverse effects

Systematic review: Antibiotics administered for acute otitis media have modest benefits and adverse effects Antibiotics administered for acute otitis media have modest benefits and adverse effects | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Antibiotics administered for acute otitis media have modest benefits and adverse effects Article Text Therapeutics/Prevention Systematic review Antibiotics administered for acute otitis media have

2016 Evidence-Based Medicine

32. Otitis Media with Effusion (OME)

Otitis Media with Effusion (OME) Clinical Practice Guideline: Otitis Media with Effusion (Update) - Richard M. Rosenfeld, Jennifer J. Shin, Seth R. Schwartz, Robyn Coggins, Lisa Gagnon, Jesse M. Hackell, David Hoelting, Lisa L. Hunter, Ann W. Kummer, Spencer C. Payne, Dennis S. Poe, Maria Veling, Peter M. Vila, Sandra A. Walsh, Maureen D. Corrigan, 2016 MENU IN THIS JOURNAL Sign In Institution Society Access Options You can be signed in via any or all of the methods shown below at the same time (...) are not available for this article. For more information view the page. double-click to add/edit rich text ... Please read and accept the and check the box to generate a sharing link. I have read and accept the terms and conditions Share URL copied to clipboard View permissions information for this article Clinical Practice Guideline: Otitis Media with Effusion (Update) .entryAuthor" data-author-container-selector=".NLM_contrib-group"> Show all authors , MD, MPH 1 1Department of Otolaryngology, SUNY Downstate

2016 American Academy of Otolaryngology - Head and Neck Surgery

33. Purulent acute otitis media in children over 3 months

Purulent acute otitis media in children over 3 months Memo Sheet Purulent acute otitis media in children over 3 months November 2016 In case of congestive or seromucinous acute otitis media: no antibiotics. In case of purulent acute otitis media: • children 2 years with mild symptoms: no antibiotics; • children > 2 years with severe symptoms: amoxicillin, 80 or 90 mg/kg/day, for 5 days. If conjunctivitis-otitis syndrome: amoxicillin-clavulanic acid, 80 mg/kg/day, for 8-10 days

2016 HAS Guidelines

34. Purulent acute otitis media in adults

Purulent acute otitis media in adults Memo sheet Purulent acute otitis media in adults November 2016 www.has-sante.fr 5 avenue du Stade de France - 93218 Saint-Denis La Plaine CEDEX Tel.: +33(0)1 55 93 70 00 - Fax: +33(0)1 55 93 74 00 The purpose of this memo sheet is to promote the appropriate prescription of antibiotics to reduce bacterial resistance, which may lead to therapeutic impasses. The choice of antibiotic, its dose and its dosage are factors to consider for a suitable prescription

2016 HAS Guidelines

35. Otitis media with effusion

Otitis media with effusion Otitis media with effusion - NICE CKS Share Otitis media with effusion: Summary Otitis media with effusion (OME), also known as 'glue ear', is characterized by a collection of fluid within the middle ear space without signs of acute inflammation. OME is the most common cause of hearing impairment in childhood. The hearing loss usually resolves over several weeks or months, but may be more persistent and, if bilateral, may lead to developmental problems. Symptoms (...) of OME vary with time and the age of the child. OME is most common in young children, with the incidence highest in those aged 2 and 5 years. It presents most commonly in the winter months. The exact cause of OME is uncertain, but over 50% of cases are thought to follow an episode of acute otitis media, especially in children under 3 years of age. Persistence of OME may be caused by one or more of the following: Impaired eustachian tube function causing poor aeration of the middle ear. Low-grade

2016 NICE Clinical Knowledge Summaries

36. The management of Otitis Media with Effusion in children with cleft palate (mOMEnt): a feasibility study and economic evaluation Full Text available with Trip Pro

The management of Otitis Media with Effusion in children with cleft palate (mOMEnt): a feasibility study and economic evaluation The management of Otitis Media with Effusion in children with cleft palate (mOMEnt): a feasibility study and economic evaluation Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website

2015 NIHR HTA programme

37. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial Full Text available with Trip Pro

Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial Otitis media with effusion is a common problem that lacks an evidence-based nonsurgical treatment option. We assessed the clinical effectiveness of treatment with a nasal balloon device in a primary care setting.We conducted an open, pragmatic randomized controlled trial set in 43 family practices in the United Kingdom. Children aged 4-11 years with a recent (...) history of ear symptoms and otitis media with effusion in 1 or both ears, confirmed by tympanometry, were allocated to receive either autoinflation 3 times daily for 1-3 months plus usual care or usual care alone. Clearance of middle-ear fluid at 1 and 3 months was assessed by experts masked to allocation.Of 320 children enrolled, those receiving autoinflation were more likely than controls to have normal tympanograms at 1 month (47.3% [62/131] v. 35.6% [47/132]; adjusted relative risk [RR] 1.36, 95

2015 EvidenceUpdates Controlled trial quality: predicted high

38. Assessment of the feasibility and clinical value of further research to evaluate the management options for children with Down syndrome and otitis media with effusion: a feasibility study

Assessment of the feasibility and clinical value of further research to evaluate the management options for children with Down syndrome and otitis media with effusion: a feasibility study Assessment of the feasibility and clinical value of further research to evaluate the management options for children with Down syndrome and otitis media Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you

2014 NIHR HTA programme

39. Ciloxan (Ciprofloxacin) - otitis externa or otitis media

Ciloxan (Ciprofloxacin) - otitis externa or otitis media 1/16 The legally binding text is the original French Version TRANSPARENCY COMMITTEE OPINION 19 October 2011 CILOXAN 3 mg/ml, ear drops, solution B/1 bottle of 5 ml (CIP code: 3601303) Applicant: ALCON FRANCE Ciprofloxacin ATC code: S02AA (antibiotic from the fluoroquinolone family) List I Date of Marketing Authorisation: 28 November 2002, amendment of 14 May 2008 Reason for request: Inclusion on the list of medicines refundable (...) by National Health Insurance and approved for hospital use. Medical, Economic and Public Health Assessment Division 2/16 1 CHARACTERISTICS OF THE MEDICINAL PRODUCT 1.1. Active ingredient Ciprofloxacin 1.2. Indication "Antibiotic treatment for adults and children from 1 year: - for acute otitis externa - for purulent otorrhea of the mastoid cavity and chronic suppurative otitis media with tympanic perforation. Consideration should be given to official guidance on the appropriate use of antibacterial agents

2014 Haute Autorite de sante

40. Pneumococcal conjugate vaccines for preventing otitis media. Full Text available with Trip Pro

Pneumococcal conjugate vaccines for preventing otitis media. Acute otitis media (AOM) is a very common respiratory infection in early infancy and childhood. The marginal benefits of antibiotics for AOM in low-risk populations in general, the increasing problem of bacterial resistance to antibiotics and the huge estimated direct and indirect annual costs associated with otitis media (OM) have prompted a search for effective vaccines to prevent AOM.To assess the effect of pneumococcal conjugate

2014 Cochrane